Go to JCI Insight
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Publication ethics
  • Publication alerts by email
  • Advertising
  • Job board
  • Contact
  • Clinical Research and Public Health
  • Current issue
  • Past issues
  • By specialty
    • COVID-19
    • Cardiology
    • Gastroenterology
    • Immunology
    • Metabolism
    • Nephrology
    • Neuroscience
    • Oncology
    • Pulmonology
    • Vascular biology
    • All ...
  • Videos
    • Conversations with Giants in Medicine
    • Video Abstracts
  • Reviews
    • View all reviews ...
    • Complement Biology and Therapeutics (May 2025)
    • Evolving insights into MASLD and MASH pathogenesis and treatment (Apr 2025)
    • Microbiome in Health and Disease (Feb 2025)
    • Substance Use Disorders (Oct 2024)
    • Clonal Hematopoiesis (Oct 2024)
    • Sex Differences in Medicine (Sep 2024)
    • Vascular Malformations (Apr 2024)
    • View all review series ...
  • Viewpoint
  • Collections
    • In-Press Preview
    • Clinical Research and Public Health
    • Research Letters
    • Letters to the Editor
    • Editorials
    • Commentaries
    • Editor's notes
    • Reviews
    • Viewpoints
    • 100th anniversary
    • Top read articles

  • Current issue
  • Past issues
  • Specialties
  • Reviews
  • Review series
  • Conversations with Giants in Medicine
  • Video Abstracts
  • In-Press Preview
  • Clinical Research and Public Health
  • Research Letters
  • Letters to the Editor
  • Editorials
  • Commentaries
  • Editor's notes
  • Reviews
  • Viewpoints
  • 100th anniversary
  • Top read articles
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Publication ethics
  • Publication alerts by email
  • Advertising
  • Job board
  • Contact
Gsα deficiency in the dorsomedial hypothalamus underlies obesity associated with Gsα mutations
Min Chen, … , Oksana Gavrilova, Lee S. Weinstein
Min Chen, … , Oksana Gavrilova, Lee S. Weinstein
Published December 19, 2016
Citation Information: J Clin Invest. 2017;127(2):500-510. https://doi.org/10.1172/JCI88622.
View: Text | PDF
Research Article Metabolism

Gsα deficiency in the dorsomedial hypothalamus underlies obesity associated with Gsα mutations

  • Text
  • PDF
Abstract

Gsα, encoded by Gnas, mediates hormone and neurotransmitter receptor–stimulated cAMP generation. Heterozygous Gsα-inactivating mutations lead to obesity in Albright hereditary osteodystrophy (AHO) patients, but only when the mutations occur on the maternal allele. This parent-of-origin effect is due to Gsα imprinting in the CNS, although the relevant CNS regions are unknown. We have now shown that mice with a Gnas gene deletion disrupting Gsα expression on the maternal allele, but not the paternal allele, in the dorsomedial nucleus of the hypothalamus (DMH) developed obesity and reduced energy expenditure without hyperphagia. Although maternal Gnas deletion impaired activation of brown adipose tissue (BAT) in mice, their responses to cold environment remained intact. Similar findings were observed in mice with DMH-specific deficiency of melanocortin MC4R receptors, which are known to activate Gsα. Our results show that Gsα imprinting in the DMH underlies the parent-of-origin metabolic phenotype that results from Gsα mutations and that DMH MC4R/Gsα signaling is important for regulation of energy expenditure and BAT activation, but not the metabolic response to cold.

Authors

Min Chen, Yogendra B. Shrestha, Brandon Podyma, Zhenzhong Cui, Benedetta Naglieri, Hui Sun, Thuy Ho, Eric A. Wilson, Yong-Qi Li, Oksana Gavrilova, Lee S. Weinstein

×

Figure 3

Glucose metabolism in mDMHGsKO and pDMHGsKO mice.

Options: View larger image (or click on image) Download as PowerPoint
Glucose metabolism in mDMHGsKO and pDMHGsKO mice.
(A and B) Results of g...
(A and B) Results of glucose tolerance tests (glucose curve, left; AUC, right) performed on (A) mDMHGsKO mice (n = 7–9/group) and (B) pDMHGsKO mice (n = 5–7/group) and their respective controls. (C and D) Results of insulin tolerance tests (glucose curves as percentage of baseline, left; area below baseline [ABB], right) performed in (C) mDMHGsKO mice (n = 7–10/group) and (D) pDMHGsKO mice (n = 4–6/group) and their respective controls. Experiments in parts A–D were performed in mice at 2.5 to 3 months after injection. (E) Glucose tolerance test (glucose curve, left; AUC, right) performed on mDMHGsKO and control mice at 2 weeks after injection (n = 4–6/group). (F) Body weight of mice at the time of glucose tolerance tests shown in part E. (G) Fasting blood glucose levels in mDMHGsKO and control mice at 2 weeks after viral injection. (H) Serum insulin levels at time 0 and 120 minutes during glucose tolerance tests shown in part E. Data are shown as mean ± SEM. *P < 0.05 vs. controls by Student’s t test.

Copyright © 2025 American Society for Clinical Investigation
ISSN: 0021-9738 (print), 1558-8238 (online)

Sign up for email alerts